Skip to main content
. 2010 Jun 17;11(6):2499–2522. doi: 10.3390/ijms11062499

Table 1.

Controversial hypocholesterolemic effects of prebiotic and synbiotic.

Compound(s) Experimental design Subjects Dose; duration of the study Effects Ref.
Inulin Randomized, placebo-controlled, double-blind & crossover. 8 volunteers. 3–4 g/100 of inulin & wheat fiber daily for 12 weeks. No significant improvement in lipid profiles. [62]
Fructooligo-saccharides (FOS) Randomized, placebo-controlled, double-blind & crossover. 10 diabetic patients (6 men and 4 women); with plasma TC of 4.85–5.58 mmol/L. 20 g FOS/day for 4 weeks. No significant improvement in lipid profiles. [63]
Inulin Randomized, placebo-controlled, double-blind & crossover designed study; with 2 six-week treatment periods, separated by a six-week washout period. 25 subjects; with baseline LDL-C ranging from 3.36–5.17 mmol/L. 45 g chocolate bar (containing of 18 g of inulin) daily during treatment period. No significant improvement in lipid profiles. [64]
L. acidophilus&B. longum& fructooligo-saccharides (FOS) Randomized, single-blind, placebo-controlled & parallel. 55 normocholesterolemic volunteers. 3 capsules of synbiotics product (consisted of 109 CFU/g of L. acidophilus & B. longum, & 10–15 mg of FOS) once daily for 2 months. No significant improvement in lipid profiles. [65]

TC: Total cholesterol; LDL-C: Low-density lipoprotein cholesterol.